CORDIS Project

Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus

Solnatide·101003595·H2020

Funding breakdown and partner intelligence are Premium

Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1

Upgrade

Start free • Cancel anytime • 14-day refund guarantee

View on CORDIS DOI grant

Funding data

Programme: Horizon 2020
Participants: 4
Start - End: 01/04/2020 — 30/06/2022
Status: CLOSED

Summary

This project focuses on developing Solnatide, a peptide-based treatment for patients suffering from Acute Respiratory Distress Syndrome and life-threatening pulmonary edema caused by 2019-nCoV infections. The aim is to demonstrate the safety and efficacy of Solnatide in clinical trials, addressing a critical gap in ava…

Full AI summary and premium intelligence

Upgrade to Premium for the complete AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Objective

Clinical features of patients infected with the 2019-nCoV have revealed that these patients suffer from severe respiratory failure, and presence of a life-threatening pulmonary oedema (PPO).

Approx. 30% of 2019-nCoV-patients further develop life-threatening Acute Respiratory Distress Syndrome (ARDS).

Mortality rate of these patients is very high.Initiator and Scientific Coordinator of the project, APEPTICO, is a SME biotechnology company (EMEA/SME/012/09) developing peptide-based products target…

Full objective and premium intelligence

Upgrade to Premium for the complete objective, AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Coordinator

RTDS Association (RTDS)

RTDS - VEREIN ZUR FORDERUNG DER KOMMUNIKATION UND VERMITTLUNG VON FORSCHUNG, TECHNOLOGIE UND INNOVATION (RTDS VEREIN, ENGL. RTDS ASSOCIATION)

Country: Austria, WIEN
Organization type: Other
Activity type: Other
SME: Yes

Network and participants(4 participants)

Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.

OPIS GERMANY GMBH
Germany, MUNICH
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
thirdparty
OPIS SRL
Italy, PALAZZO ALIPRANDI
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
participant
LMU MUENCHEN
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
BCN PEPTIDES
Spain, SANTA QUINTI DE MEDIONA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
participant

4 participants shown of 6

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Partner & research intelligence

Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.

Consortium analytics and research context are Premium

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

CORDIS call / funding scheme

Programme: H2020
Call: H2020-SC1-PHE-CORONAVIRUS-2020
Sub call: H2020-SC1-PHE-CORONAVIRUS-2020
Funding scheme: RIA - Research and Innovation action
Domain note: This block describes the CORDIS project call context. Live open opportunities are managed in the Funding & Tenders domain.

Fields of Science (EuroSciVoc)

Guests see up to 5 EuroSciVoc fields.

Medical and health sciencesHealth sciencesInfectious diseasesRNA virusesCoronaviruses

Topic

Guests see up to 5 topics.

SC1-PHE-CORONAVIRUS-2020